SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60
http://www.w3.org/2000/01/rdf-schema#comment
"CD109 is present in serum as a soluble form and suggest its potential as a novel tumor marker in patients with cancers that express CD109."
xsd:string
http://purl.uniprot.org/uniprot/#_442C354DB702F076995A362DFAE381DFFA576CB272C658CD4C604ADC19E16385111587A5F556AEEF10AAE0616626C4B3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60
http://purl.uniprot.org/uniprot/Q8R422
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60
http://purl.uniprot.org/uniprot/#_Q8R422-mappedCitation-24400073
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CFB40567D5F4AEF52F2FD7E4A0924C79B384A52D96724429426742055F8E0F104D19B44475C5C5760E889108AE3E9C60